Mary Kay Fenton, Chief Financial Officer at Cullinan Therapeutics, Inc. (CGEM), sold 4,398 shares at $13.62 ($60K) on 2026-02-20, disclosed to the SEC on 2026-02-23.
Open-market sale of $60k CGEM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ACHN | SELL | 2015-01-23 | $210K | — | Filing → |
| ACHN | SELL | 2012-01-11 | $168K | — | Filing → |
| ACHN | SELL | 2011-04-06 | $32K | — | Filing → |